Balance Sheet

v3.7.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 596,761 $ 3,979,290
Prepaid expenses 198,756 281,858
Other current assets 10,000 32,830
Total current assets 805,517 4,293,978
Property and equipment, net 686,284 731,712
Goodwill 6,826,003 6,826,003
Other long term assets 337,240 168,597
Total assets 8,655,044 12,020,290
Current liabilities:    
Accounts payable 1,724,443 1,137,903
Accrued compensation 704,322 770,592
Accrued clinical operations and site costs 1,596,836 1,218,641
Accrued lease contingency fee 590,504 590,504
Other accrued expenses 403,340 315,034
Interest payable 50,562 51,295
Current portion of notes payable 1,666,667 1,589,661
Current portion of capital leases payable 17,361 17,004
Total current liabilities 6,754,035 5,690,634
Long-term liabilities:    
Long-term portion of notes payable, net 2,603,176 2,774,627
Long-term portion of capital leases 63,636 68,113
Other long-term liabilities 157,118 144,394
Total long-term liabilities 2,823,930 2,987,134
Total liabilities 9,577,965 8,677,768
Commitments and contingencies:
Stockholders’ (Deficit) Equity:    
Common stock, $0.01 par value; 150,000,000 shares authorized, 6,316,110 and 6,296,110 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively 63,161 62,961
Additional paid-in capital 82,622,722 81,533,511
Accumulated deficit (83,617,115) (78,262,261)
Total stockholders’ (deficit) equity (922,921) 3,342,522
Total liabilities and stockholders’ (deficit) equity 8,655,044 12,020,290
Series D Convertible Preferred Stock [Member]    
Stockholders’ (Deficit) Equity:    
Preferred stock 1,325 1,325
Series E Convertible Preferred Stock [Member]    
Stockholders’ (Deficit) Equity:    
Preferred stock 333 333
Series F Convertible Preferred Stock [Member]    
Stockholders’ (Deficit) Equity:    
Preferred stock $ 6,653 $ 6,653

Source